Date: Jul 22, 2015 Author: Gulli Arnason Source: Financial New UK (
click here to go to the source)
Implant Sciences Corporation (OTCQB: IMSC) said that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports.
Over the past few months, Implant Sciences has won a series of tenders in France, as well as throughout the EU. Following its two recent airport tender wins in France, the company´s ETDs have been selected for deployment in over 95 percent of the French airports that serve more than 500,000 passengers annually.
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCalâ„¢ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs.
